Redona Therapeutics has filed a notice of an exempt offering of securities to raise $11,907,796.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Redona Therapeutics is raising $11,907,796.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Kazumi Shiosaki played a…